News

Can Artificial Intelligence Help Personalize Treatment for Cardiology Patients?

16. 5. 2024 Source:

According to data from the World Health Organization (WHO), cardiovascular diseases (CVDs) claim an estimated 17.9 million lives annually worldwide, making them the leading cause of death. More than 4 out of 5 of these deaths are due to heart attacks and strokes, and one-third occur in people under the age of 70. An innovative project called NextGen will newly address cardiovascular diseases. Its goal is to use artificial intelligence (AI) and patient health information and genetic profiles to personalize their treatment. The project received…

Expert Consensus on the Use of Bimekizumab in the Treatment of Plaque Psoriasis and Psoriatic Arthritis

The expert consensus published in February 2024 offers guidance on the use of bimekizumab in the treatment of patients with moderate to severe plaque psoriasis and psoriatic arthritis. It is based on…

16. 5. 2024 Source: Psoriasis

Twilight of Radiologists? Will They Be Replaced by Artificial Intelligence?

Although artificial intelligence has recently made enormous progress in interpreting scans from imaging techniques, its use is still limited to a few well-defined pathologies. Tools that could…

15. 5. 2024 Source: proLékaře.cz

Neuroprotective Efficacy and Safety of Vinpocetine in Patients with Acute Ischemic Stroke

A meta-analysis of 4 randomized placebo-controlled studies demonstrated the benefits of vinpocetine in patients with ischemic stroke (iCMP). Administering vinpocetine within 14 days of the onset of the...

13. 5. 2024 Source: Pain Management

Analysis of the Benefits of Combining Enalapril/Bisoprolol in Patients with Acute MI

A recently published retrospective analysis compared the outcomes achieved by administering enalapril alone and in combination with bisoprolol in patients after acute myocardial infarction over a…

13. 5. 2024 Source: Cardiovascular Continuum

New scoring system for predicting long-term survival of AML patients over 70 years and suitable for intensive chemotherapy

Based on the analysis of data from 3 large European registries (DATAML, SAL, and PETHEMA), a prognostic score for 5-year survival was created and validated for patients with acute myeloid leukemia…

10. 5. 2024 Source: Acute Myeloid Leukemia

Maintenance Therapy of a Female Patient with AML After Intense Chemotherapy –⁠ Case Study

The following case study presents the case of a female patient with acute myeloid leukemia (AML) who experienced life-threatening complications after the second consolidation chemotherapy, rendering…

10. 5. 2024 Source: Acute Myeloid Leukemia

Efficacy and Safety of Romosozumab in Postmenopausal Women with Osteoporosis and Renal Impairment

The coexistence of osteoporosis and chronic kidney disease (CKD) increases the risk of fractures and overall mortality in patients. A recent post-hoc analysis of two controlled randomized multicenter…

9. 5. 2024 Source: Osteoporosis – Trends in Sequential Therapy

Previous Treatment of Osteoporosis May Affect the Efficacy of Romosozumab

A study conducted by a team of authors from several clinical sites in Japan shows that the type and duration of previous osteoporosis treatment just before starting romosozumab affects its…

9. 5. 2024 Source: Osteoporosis – Trends in Sequential Therapy

Will 3D Printable Tissue Adhesives Replace Stitches and Clips?

3D printing technology is slowly making its way into more and more areas of healthcare. In February 2024, a scientific team from the Massachusetts Institute of Technology (MIT) published a study in…

8. 5. 2024 Source:

Over the Last 25 Years, Latanoprost Has Changed the Paradigm of Glaucoma Treatment

An important milestone in the treatment of glaucoma was the introduction of latanoprost with an entirely new mechanism of action compared to previously used antiglaucoma medications. Prostaglandin…

7. 5. 2024 Source: Treatment of Glaucoma

New Technology Teaches Healthcare Professionals to Deliver Messages Patients Don't Want to Hear

Communication with patients and their relatives is often very challenging for doctors and nurses, especially when the patient or their family member is experiencing strong emotions. A new technology…

3. 5. 2024 Source:

EAHAD 2024: Fresh results of paradigm5 and 6 studies confirm safety and efficacy of N9-GP

Nonacog beta pegol (N9-GP) is a recombinant factor IX with an extended half-life. Its properties allow for the maintenance of a satisfactorily high level of FIX with intravenous application once a…

30. 4. 2024 Source: Hemophilia with Movement

What is the future of xenotransplantation? Pig liver and kidneys transplanted to humans for the first time

The initial successes of pig organ transplants to humans, conducted this March, gave hope that clinical trials of these procedures could soon become a reality. What path then leads to the clinical…

30. 4. 2024 Source:

Updated Recommendations of the European Society of Cardiology for the Treatment of HCM

Newly published guidelines by the European Society of Cardiology (ESC) bring several updates in the care of patients with cardiomyopathies. In the following excerpt, we focus on new recommendations…

28. 4. 2024 Source: Hypertrophic Cardiomyopathy (HCM)

1 … 11 12 13 14 15 … 115

Back Filter by speciality

Remove filters

Popular this week